StockData
CVRx, Inc. logo

CVRx, Inc. (CVRX) stock

CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3091% below fair value
$0.60−0.01 (-1.15%)

Close on Nov 18, 2026Market cap $16.09MP/E –Yield –

CVRx operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

CVRx's operating income for the twelve months ending Jun 30, 2026 was -$48.64M. For fiscal 2025 it was -$51.27M. The highest annual figure on record is -$11.51M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$51.27M–
FY2024Dec 31, 2024-$59.49M–
FY2023Dec 31, 2023-$43.10M–
FY2022Dec 31, 2022-$42.53M–
FY2021Dec 31, 2021-$25.97M–
FY2020Dec 31, 2020-$11.51M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$13.02M–
Q1 FY2026Mar 31, 2026-$12.16M–
Q4 FY2025Dec 31, 2025-$11.18M–
Q3 FY2025Sep 30, 2025-$12.27M–
Q2 FY2025Jun 30, 2025-$14.38M–
Q1 FY2025Mar 31, 2025-$13.44M–
Q4 FY2024Dec 31, 2024-$10.27M–
Q3 FY2024Sep 30, 2024-$13.01M–
Q2 FY2024Jun 30, 2024-$13.97M–
Q1 FY2024Mar 31, 2024-$22.23M–
Q4 FY2023Dec 31, 2023-$9.66M–
Q3 FY2023Sep 30, 2023-$9.53M–
Q2 FY2023Jun 30, 2023-$11.75M–
Q1 FY2023Mar 31, 2023-$12.16M–
Q4 FY2022Dec 31, 2022-$11.48M–
Q3 FY2022Sep 30, 2022-$10.13M–
Q2 FY2022Jun 30, 2022-$11.01M–
Q1 FY2022Mar 31, 2022-$9.91M–
Q4 FY2021Dec 31, 2021-$8.79M–
Q3 FY2021Sep 30, 2021-$7.29M–
Q2 FY2021Jun 30, 2021-$5.67M–
Q1 FY2021Mar 31, 2021-$4.22M–
Q4 FY2020Dec 31, 2020-$2.14M–
Q3 FY2020Sep 30, 2020-$3.04M–
Q2 FY2020Jun 30, 2020-$3.06M–

More CVRx figures

See a number that looks wrong?